CWGCX
Price
$68.12
Change
+$0.24 (+0.35%)
Updated
Jun 6 closing price
Net Assets
130.86B
VSQRX
Price
$17.08
Change
+$0.13 (+0.77%)
Updated
Jun 6 closing price
Net Assets
17.27M
Interact to see
Advertisement

CWGCX vs VSQRX

Header iconCWGCX vs VSQRX Comparison
Open Charts CWGCX vs VSQRXBanner chart's image
American Funds Capital World Gr&Inc C
Price$68.12
Change+$0.24 (+0.35%)
VolumeN/A
Net Assets130.86B
Invesco MSCI World SRI Index R
Price$17.08
Change+$0.13 (+0.77%)
VolumeN/A
Net Assets17.27M
CWGCX vs VSQRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CWGCX vs. VSQRX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a Buy and VSQRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 131B vs. VSQRX (17.3M). VSQRX pays higher dividends than CWGCX: VSQRX (1.15) vs CWGCX (0.87). CWGCX was incepted earlier than VSQRX: CWGCX (24 years) vs VSQRX (9 years). VSQRX (2.70) is less costly to investors than CWGCX (1.49). VSQRX is a more actively managed with annual turnover of: 32.00 vs. CWGCX (27.00). CWGCX has a lower initial minimum investment than VSQRX: CWGCX (250) vs VSQRX (1000). CWGCX annual gain was more profitable for investors over the last year : 5.53 vs. VSQRX (1.62). VSQRX return over 5 years is better than : 56.51 vs. CWGCX (42.30).
CWGCXVSQRXCWGCX / VSQRX
Total Expense Ratio1.490.69216%
Annual Report Gross Expense Ratio1.492.7055%
Fund Existence24 years9 years-
Gain YTD8.7113.228270%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets131B17.3M757,225%
Annual Yield % from dividends0.871.1576%
Returns for 1 year5.531.62341%
Returns for 3 years26.8625.08107%
Returns for 5 years42.3056.5175%
Returns for 10 years49.31N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV6.200.47
+8.12%
Verve Therapeutics
PIII6.620.14
+2.24%
P3 Health Partners Inc
VSAT9.210.09
+0.99%
ViaSat
NLY19.060.18
+0.95%
Annaly Capital Management
RELI1.47-0.04
-2.65%
Reliance Global Group Inc.